Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 14;7(3):e2160.
doi: 10.1097/GOX.0000000000002160. eCollection 2019 Mar.

Consensus Recommendations for the Use of Hyperdiluted Calcium Hydroxyapatite (Radiesse) as a Face and Body Biostimulatory Agent

Ada Trindade de Almeida  1 , Vinicius Figueredo  2 , Ana Lúcia Gonzaga da Cunha  3 , Gabriela Casabona  4 , Joana Ribeiro Costa de Faria  5 , Emerson Vicente Alves  6 , Mauricio Sato  7 , Adeíza Branco  8 , Christine Guarnieri  6 , Eliandre Palermo  6   9
Affiliations

Consensus Recommendations for the Use of Hyperdiluted Calcium Hydroxyapatite (Radiesse) as a Face and Body Biostimulatory Agent

Ada Trindade de Almeida et al. Plast Reconstr Surg Glob Open. .

Abstract

Background: Calcium hydroxyapatite (CaHA) is a well-established collagen stimulator. In recent years, it has been increasingly used in hyperdiluted form as a biostimulatory agent rather than a volumizing filler to improve skin quality and firmness in both facial and corporal areas. However, guidelines on the techniques required to achieve optimal results are still lacking. The objective of this study was to develop a consensus recommendation for the safe and effective use of hyperdiluted CaHA for face and body biostimulation.

Methods: A team of 10 experts with extensive experience in dermal fillers and biostimulatory treatments for facial and body rejuvenation convened for a live meeting. Consensus was defined as approval by 70%-89% of all participants, whereas agreement of ≥90% denoted strong consensus.

Results: For most items, the group achieved a majority consensus. Recommendations have been provided for the face, neck, décolletage, buttocks, thighs, arms, abdomen, knees, and elbows with detailed injection techniques, providing information on insertion points, dosages, and volumes for both needle and cannula injections as well as the number of treatment sessions and intervals.

Conclusions: The expert consensus supports and provides guidance for the use of CaHA as a biostimulatory agent for face and body rejuvenation. However, further clinical studies are necessary to provide physicians with the best evidence for the best treatment practices.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
The face before and 8 weeks after injections of 1.5 mL of CaHA (Radiesse) diluted 1:1 with 1.5 mL of lidocaine (total of 3 syringes split in 2 sessions with a 4-week interval). Notice the improvement of skin laxity and the discrete volume gain. Courtesy of Vinicius Figueredo, MD.
Fig. 2.
Fig. 2.
Techniques for CaHA biostimulation of the face.
Fig. 3.
Fig. 3.
Techniques for CaHA biostimulation of the neck.
Fig. 4.
Fig. 4.
Techniques for CaHA application in the buttocks.
Fig. 5.
Fig. 5.
Techniques for CaHA application in the abdomen.
Fig. 6.
Fig. 6.
The upper arm before and 48 weeks after injection of 1.5 mL of CaHA (Radiesse) diluted with 6 mL of lidocaine, per side. Notice the remarkable long-term improvement of skin laxity. Courtesy of Eliandre Palermo, MD.
Fig. 7.
Fig. 7.
Technique for CaHA application in the arm.
Fig. 8.
Fig. 8.
Techniques for CaHA application in the knee.
See this image and copyright information in PMC

References

    1. Kadouch JA. Calcium hydroxylapatite: a review on safety and complications. J Cosmet Dermatol. 2017;16:152–161. - PubMed
    1. Loghem JV, Yutskovskaya YA, Philip Werschler W. Calcium hydroxylapatite: over a decade of clinical experience. J Clin Aesthet Dermatol. 2015;8:38–49. - PMC - PubMed
    1. Carruthers J, Burgess C, Day D, et al. Consensus recommendations for combined aesthetic interventions in the face using botulinum toxin, fillers, and energy-based devices. Dermatol Surg. 2016;42:586–597. - PubMed
    1. Berlin AL, Hussain M, Goldberg DJ. Calcium hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg. 2008;34(suppl 1):S64–S67. - PubMed
    1. Tzikas TL. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation. Dermatol Surg. 2008;34(suppl 1):S9–S15. - PubMed